Ruxolitinib 15 mg, tablet, PO

By: Linazka Calvo๐Ÿ“ PanamaOpen

Key Information

ReferenceGB-2026-1-10-01-08-SLP-000829
DeadlineNov 9, 2026 12:00 AM
CategoryAdvertising & Media
Competition TypeICB
Funding SourceSelf-Funded
CountryPanama
AddressPA
PublishedOct 22, 2026

Description

RUXOLITINIB.

Full details are available after unlocking this tender.